ISB News

ISB Hosts TCGA Meeting

Ilya Shmulevich, PhD, ISB Faculty

Ilya Shmulevich, PhD, shares this message about our hosting a TCGA (The Cancer Genome Atlas) steering committee meeting at ISB. In the video below, Ilya explains the purpose of the meeting and chats briefly about “pan-cancer” – the effort to find commonalities among multiple cancers.

Related content: Read about ISB’s role in TCGA as a Genome Data Analysis Center and about the most recent collaborative paper on endometrial cancer, which was published on May 1 in the journal Nature and covered by The New York Times.

 

Recent Articles

  • Timing is Everything: ISB Study Finds Link Between Bowel Movement Frequency and Overall Health

    Everybody poops, but not every day. An ISB-led research team examined the clinical, lifestyle, and multi-omic data of more than 1,400 healthy adults. How often people poop, they found, can have a large influence on one’s physiology and health.

  • Wei Wei, PhD

    Dr. Wei Wei Promoted to Associate Professor

    Wei Wei, PhD – an accomplished cancer researcher with expertise in biotechnology and cancer systems biology – has been promoted to ISB associate professor. The Wei Lab focuses on understanding how cancer cells adapt to therapeutic treatment to foster therapy resistance by coordinating their internal molecular machinery and how these adaptive changes evolve within diverse tumors influenced by the tumor microenvironment. 

  • Drs. Nitin Baliga and James Park

    How Glioblastoma Resists Treatment – and Ways to Prevent It

    Glioblastoma is one of the deadliest and most aggressive forms of primary brain cancer in adults and is known for its ability to resist treatment and to recur. ISB researchers have made breakthrough discoveries in understanding the mechanisms behind acquired resistance, focusing on a rare and stubborn group of cells within tumors called glioma stem-like cells.